LAQUITA BAIN: Open Payments
NPI 1437238938 · CORINTH, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,353 in 82 payments from 20 companies in 2025. Trend: 2023 $1,456 · 2024 $1,309 · 2025 $1,353
Food & beverage: $1,353
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 19 | $299 |
| Otsuka America Pharmaceutical, Inc. | 11 | $164 |
| PFIZER INC. | 13 | $162 |
| Electromed, Inc. | 6 | $158 |
| Amgen Inc. | 6 | $96 |
| AstraZeneca Pharmaceuticals LP | 5 | $73 |
| GlaxoSmithKline, LLC. | 4 | $60 |
| Lilly USA, LLC | 3 | $47 |
| Axsome Therapeutics, Inc. | 2 | $43 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $35 |
Products named: REXULTI, SMARTVEST, NURTEC ODT, AVYCAZ, DALVANCE, EVENITY, ELIQUIS, TRELEGY ELLIPTA.
Industry payments across MS — which companies pay providers there.
